ImmunoPrecise Antibodies Profit Margin 2022-2025 | IPA
Current and historical gross margin, operating margin and net profit margin for ImmunoPrecise Antibodies (IPA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ImmunoPrecise Antibodies net profit margin as of January 31, 2025 is -190.76%.
| ImmunoPrecise Antibodies Annual Profit Margins |
|---|
| ImmunoPrecise Antibodies Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.021B | $0.018B |
| ImmunoPrecise Antibodies Ltd. is a technology platform company with end-to-end solutions empowering companies to discover and develop therapies against any disease. ImmunoPrecise Antibodies Ltd. is based in VICTORIA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.476B | 53.14 |
| Tempus AI (TEM) | United States | $9.826B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.069B | 145.79 |
| Inspire Medical Systems (INSP) | United States | $4.756B | 92.38 |
| IRhythm Technologies (IRTC) | United States | $4.186B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $2.016B | 12.47 |
| Schrodinger (SDGR) | United States | $1.847B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.706B | 0.00 |
| Phreesia (PHR) | United States | $1.512B | 0.00 |
| Omnicell (OMCL) | United States | $1.460B | 31.48 |
| Azenta (AZTA) | United States | $1.232B | 57.36 |
| 10x Genomics (TXG) | United States | $1.031B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 319.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.456B | 0.00 |
| TruBridge (TBRG) | United States | $0.392B | 0.00 |
| Claritev (CTEV) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.294B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.208B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.202B | 0.00 |
| Pulmonx (LUNG) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.085B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.43 |
| 111 (YI) | China | $0.072B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |